chitosan has been researched along with isoniazid in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (8.33) | 29.6817 |
| 2010's | 15 (62.50) | 24.3611 |
| 2020's | 7 (29.17) | 2.80 |
| Authors | Studies |
|---|---|
| Anandan, R; Mathew, PT; Santhosh, S; Sini, TK | 2 |
| Aminabhavi, TM; Angadi, SC; Manjeshwar, LS | 1 |
| Feng, Y; Gao, Y; Li, B; Ma, B; Zhou, Y; Zhu, R | 2 |
| Eslahi, H; Fazeli, MR; Gilani, K; Jamalifar, H; Moazeni, E; Pourshahab, PS | 1 |
| Buys, GM; du Plessis, LH; Hamman, JH; Kotze, AF; Marais, AF | 1 |
| Garg, T; Goyal, AK; Rath, G | 1 |
| Berezin, AS; Skorik, YA | 1 |
| Garg, T; Goyal, AK; Gupta, P; Gupta, UD; Rath, G | 1 |
| Cunha-Filho, MSS; Faccioli, LH; Gelfuso, GM; Gratieri, T; Matos, BN; Oliveira, PM; Pereira, PAT | 1 |
| Dwivedi, H; Kushwaha, K | 1 |
| Cai, X; Chen, T; Guo, L; Liao, W; Ma, D; Tan, W; Wang, W; Wu, T; Xiang, W; Yu, W; Zhang, J; Zhou, J | 1 |
| Chen, G; Li, R; Luo, W; Ma, G; Wu, Y; Yu, D; Zhang, C | 1 |
| El-Tantawy, NM; Maziad, NA; Omar, SM | 1 |
| Buttini, F; Cunha, L; Faleiro, L; Grenha, A; Rodrigues, S; Rosa da Costa, AM | 1 |
| Haware, RV; Iyer, M; Meruva, S; Rathod, V; Stagner, WC; Staton, S | 1 |
| Ansari, M; Farhadian, N; Moradi, S; Shahlaei, M; Shekarbeygi, Z | 1 |
| Manimohan, M; Paulpandiyan, R; Pugalmani, S; Sithique, MA | 1 |
| Ambrus, R; Benke, E; Burián, K; Csóka, I; Farkas, Á; Kókai, D; Mukhtar, M; Pallagi, E; Zeeshan, M | 1 |
| Changsan, N; Sinsuebpol, C | 1 |
| Cui, X; Hao, Y; Li, G; Li, L; Li, Y; Ma, Y; Sha, X; Tang, PF; Wang, H; Wang, L; Zhang, K; Zhang, Z; Zhou, J | 1 |
| Abdallah, HM; Abdel-Aziz, MM; Abu Elella, MH; Gamal, H; Goda, ES | 1 |
| Abdallah, HM; Abdel-Aziz, MM; Abu Elella, MH | 1 |
24 other study(ies) available for chitosan and isoniazid
| Article | Year |
|---|---|
Effect of chitosan supplementation on antitubercular drugs-induced hepatotoxicity in rats.
Topics: Animals; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Chitosan; Cholesterol; Fatty Acids, Nonesterified; Isoniazid; Lipid Peroxidation; Lipid Peroxides; Liver; Liver Function Tests; Male; Rats; Rats, Wistar; Rifampin; Triglycerides | 2006 |
Hepatoprotective activity of chitosan against isoniazid and rifampicin-induced toxicity in experimental rats.
Topics: Analysis of Variance; Animals; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Chitosan; Isoniazid; Lipid Peroxidation; Liver; Liver Function Tests; Male; Protective Agents; Rats; Rats, Wistar; Rifampin | 2007 |
Interpenetrating polymer network blend microspheres of chitosan and hydroxyethyl cellulose for controlled release of isoniazid.
Topics: Buffers; Calorimetry, Differential Scanning; Cellulose; Chitosan; Delayed-Action Preparations; Diffusion; Drug Carriers; Hydrogen-Ion Concentration; Isoniazid; Microscopy, Electron, Scanning; Microspheres; Particle Size; Spectroscopy, Fourier Transform Infrared; Thermogravimetry; X-Ray Diffraction | 2010 |
Formation of concentric multilayers in a chitosan hydrogel inspired by Liesegang ring phenomena.
Topics: Antitubercular Agents; Chitosan; Diffusion; Drug Carriers; Hydrogel, Polyethylene Glycol Dimethacrylate; Hydrogen Bonding; Hydroxides; Ions; Isoniazid; Kinetics; Microscopy, Electron, Scanning; Models, Chemical; Porosity; Sodium Hydroxide; Solutions; Static Electricity; Water | 2011 |
Preparation and characterization of spray dried inhalable powders containing chitosan nanoparticles for pulmonary delivery of isoniazid.
Topics: Administration, Inhalation; Aerosols; Antitubercular Agents; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Humans; Isoniazid; Mycobacterium avium-intracellulare Infection; Nanoparticles; Particle Size; Polyphosphates; Powders | 2011 |
Formation of concentric multi-layer chitosan hydrogel loaded with isoniazid.
Topics: Acetic Acid; Chemistry, Pharmaceutical; Chitosan; Diffusion; Drug Carriers; Drug Compounding; Hydrogels; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Isoniazid; Kinetics; Microscopy, Electron, Scanning; Models, Chemical; Sodium Hydroxide; Solubility; Spectrophotometry, Ultraviolet; Technology, Pharmaceutical | 2011 |
Direct compression of chitosan: process and formulation factors to improve powder flow and tablet performance.
Topics: Antitubercular Agents; Chemistry, Pharmaceutical; Chitosan; Citric Acid; Compressive Strength; Drug Compounding; Excipients; Isoniazid; Particle Size; Pectins; Powders; Solubility; Tablets; Tensile Strength | 2013 |
Inhalable chitosan nanoparticles as antitubercular drug carriers for an effective treatment of tuberculosis.
Topics: Administration, Inhalation; Animals; Antibiotics, Antitubercular; Chitosan; Disease Models, Animal; Drug Carriers; Female; Humans; Isoniazid; Mice; Mice, Inbred BALB C; Nanoparticles; Rifampin; Tuberculosis, Pulmonary | 2016 |
Chitosan-isoniazid conjugates: Synthesis, evaluation of tuberculostatic activity, biodegradability and toxicity.
Topics: Animals; Antitubercular Agents; Chitosan; Cytostatic Agents; Gastropoda; Isoniazid; Mice; Mycobacterium tuberculosis | 2015 |
Chemotherapeutic Evaluation of Guar Gum Coated Chitosan Nanoparticle Against Experimental Tuberculosis.
Topics: Animals; Antitubercular Agents; Chitosan; Coated Materials, Biocompatible; Delayed-Action Preparations; Diffusion; Female; Galactans; Isoniazid; Mannans; Mice; Mice, Inbred BALB C; Nanocapsules; Plant Gums; Rifampin; Treatment Outcome; Tuberculosis | 2016 |
Microparticles prepared with 50-190kDa chitosan as promising non-toxic carriers for pulmonary delivery of isoniazid.
Topics: Animals; Cell Line; Chitosan; Drug Carriers; Isoniazid; Macrophages, Alveolar; Mice; Microspheres; Particle Size | 2017 |
Interfacial Phenomenon Based Biocompatible Alginate-Chitosan Nanoparticles Containing Isoniazid and Pyrazinamide.
Topics: Alginates; Antitubercular Agents; Biocompatible Materials; Chitosan; Drug Carriers; Drug Liberation; Isoniazid; Nanoparticles; Particle Size; Pyrazinamide | 2018 |
Genipin-crosslinked carboxymethyl chitosan nanogel for lung-targeted delivery of isoniazid and rifampin.
Topics: Anti-Bacterial Agents; Chitosan; Cross-Linking Reagents; Drug Delivery Systems; Drug Resistance, Multiple, Bacterial; Gels; Iridoids; Isoniazid; Lung; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nanoparticles; Rifampin | 2018 |
Isoniazid-loaded chitosan/carbon nanotubes microspheres promote secondary wound healing of bone tuberculosis.
Topics: Animals; Antitubercular Agents; Chitosan; Delayed-Action Preparations; Guinea Pigs; Isoniazid; Mycobacterium tuberculosis; Nanotubes, Carbon; Rats; Tuberculosis, Osteoarticular | 2019 |
Pulmonary Delivery of Isoniazid in Nanogel-Loaded Chitosan Hybrid Microparticles for Inhalation.
Topics: Administration, Inhalation; Antitubercular Agents; Chitosan; Drug Carriers; Drug Liberation; Isoniazid; Lung; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nanogels; Particle Size; Povidone; Succinates; Tissue Distribution | 2019 |
Inhalable chitosan microparticles for simultaneous delivery of isoniazid and rifabutin in lung tuberculosis treatment.
Topics: A549 Cells; Administration, Inhalation; Antitubercular Agents; Cell Line, Tumor; Chitosan; Drug Carriers; Humans; Isoniazid; Lung; Macrophages, Alveolar; Nanoparticles; Particle Size; Rifabutin; Tuberculosis, Pulmonary | 2019 |
Human volunteer, in vitro, and molecular level evaluation of an optimized taste-masked isoniazid-chitosan spray-dried microparticle matrix.
Topics: Adult; Chitosan; Drug Compounding; Female; Healthy Volunteers; Humans; Isoniazid; Male; Microspheres; Particle Size; Polyphosphates; Taste; Young Adult | 2019 |
An innovative green sensing strategy based on Cu-doped Tragacanth/Chitosan nano carbon dots for Isoniazid detection.
Topics: Antitubercular Agents; Biopolymers; Biosensing Techniques; Calibration; Carbon; Chitosan; Copper; Electrons; Green Chemistry Technology; Humans; Iron; Isoniazid; Microscopy, Electron, Scanning; Nanotechnology; Oxidation-Reduction; Quantum Dots; Serum; Spectrometry, Fluorescence; Temperature; Tragacanth; X-Ray Diffraction | 2020 |
Biologically active Co (II), Cu (II), Zn (II) centered water soluble novel isoniazid grafted O-carboxymethyl chitosan Schiff base ligand metal complexes: Synthesis, spectral characterisation and DNA nuclease activity.
Topics: alpha-Amylases; Anti-Bacterial Agents; Antifungal Agents; Antioxidants; Chemical Phenomena; Chemistry Techniques, Synthetic; Chitosan; Cobalt; Coordination Complexes; Copper; Deoxyribonucleases; Enzyme Inhibitors; Isoniazid; Ligands; Porosity; Schiff Bases; Solubility; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Thermogravimetry; X-Ray Diffraction; Zinc | 2020 |
Aerodynamic properties and in silico deposition of isoniazid loaded chitosan/thiolated chitosan and hyaluronic acid hybrid nanoplex DPIs as a potential TB treatment.
Topics: Biopolymers; Chitosan; Drug Carriers; Dry Powder Inhalers; Humans; Hyaluronic Acid; Isoniazid; Nanoparticles; Nanostructures; Tuberculosis | 2020 |
Dry powder inhalation formulation of chitosan nanoparticles for co-administration of isoniazid and pyrazinamide.
Topics: Administration, Inhalation; Animals; Antitubercular Agents; Cell Line; Chemistry, Pharmaceutical; Chitosan; Drug Combinations; Dry Powder Inhalers; Excipients; Freeze Drying; Humans; Isoniazid; Macrophages, Alveolar; Nanoparticles; Particle Size; Polyphosphates; Pyrazinamide; Rats | 2021 |
Instant hydrogelation encapsulates drugs onto implants intraoperatively against osteoarticular tuberculosis.
Topics: Animals; Antitubercular Agents; Biocompatible Materials; Calcium Phosphates; Cell Line; Cell Survival; Chitosan; Disease Models, Animal; Drug Carriers; Drug Liberation; Femur; Glycerophosphates; Hydrogels; Isoniazid; Mice; Mycobacterium tuberculosis; Porosity; Prostheses and Implants; Rifampin; Tuberculosis, Osteoarticular | 2021 |
Green engineering of TMC-CMS nanoparticles decorated graphene sheets for targeting M. tuberculosis.
Topics: Antitubercular Agents; Centers for Medicare and Medicaid Services, U.S.; Chitosan; Graphite; Isoniazid; Metal Nanoparticles; Mycobacterium tuberculosis; Nanoparticles; United States | 2023 |
One-pot green synthesis of chitosan biguanidine nanoparticles for targeting M. tuberculosis.
Topics: Antitubercular Agents; Chitosan; Isoniazid; Mycobacterium tuberculosis; Nanoparticles | 2023 |